Press-release for stocks publishing date 2021 - 10

Prices are updated after-hours

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
Published: 2021-10-13 (Crawled : 23:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M

| 220.79% | O: 0.55% H: 1.64% C: 1.01%
A | $134.55 -1.65% -0.85% 2.1M

| -7.54% | O: 0.76% H: 1.21% C: 0.76%
fda risk cancer breast cancer approval diagnostic

Ampio Pharmaceuticals Strengthens Management Team and Board of Directors
Published: 2021-10-13 (Crawled : 13:15) - prnewswire.com
TEVA | $13.18 0.69% 0.46% 6.6M

| 33.16% | O: 0.41% H: 1.01% C: -0.61%
LLY | News | $750.77 0.54% -0.04% 3.1M

| 220.79% | O: 0.55% H: 1.64% C: 1.01%
AMRX | $5.46 0.18% 0.18% 1.2M

| -6.84% | O: -0.17% H: 1.03% C: -2.57%
FWP | $1.95 7.74% 7.18%

| -71.65% | O: -0.16% H: 9.42% C: 1.73%
AMPE | $0.3 0.0% 32K

| -82.25% | O: -1.18% H: 1.2% C: 0.0%

A Classification Scale for Alopecia Areata: It’s Time to Incorporate the Patient Experience
Published: 2021-10-13 (Crawled : 12:00) - concertpharma.com
LLY | News | $750.77 0.54% -0.04% 3.1M

| 220.79% | O: 0.55% H: 1.64% C: 1.01%

| 220.79% | O: 0.55% H: 1.64% C: 1.01%
fda risk cancer breast cancer fda approval her2+ her2- her2

Hemogenyx Pharmaceuticals Announces CDX Licence Agreement
Published: 2021-10-13 (Crawled : 10:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M

| 220.79% | O: 0.55% H: 1.64% C: 1.01%
license